The peptide synthesis market is expanding rapidly, driven by the rising incidence of chronic diseases like cancer, diabetes, and cardiovascular conditions. This surge in demand is fueled by the ...

Pharmaceutical scientists at the National University of Singapore (NUS) have developed a novel chemical reaction that enables ...

GLP-1 receptor agonists are transforming obesity treatment, but manufacturing challenges must be addressed to meet rising ...

Each year, according to the National Institutes of Health (NIH), millions of people in the U.S. are affected by spinal cord ...

In a bid to break into the CDMO business at one of its most lucrative angles, India's Granules is snapping up Swiss contract ...

Generic drugmaker Granules India is foraying into the peptide segment and contract development and manufacturing organisation ...

The Peptide-ExplorerLT ™ is designed for scientists who need to optimize and explore linear peptide synthesis. The product is a high-spec flow chemistry system that uses continuous flow. The product ...

Granules India advanced 1.95% to Rs 519 after the company said that its board has approved to acquire 100% stake in Senn Chemicals AG, a Switzerland based company, for a total consideration of Rs 192.

Granules India enters peptide segment and CDMO business by acquiring Senn Chemicals AG: Our Bureau, Bengaluru Monday, February 24, 2025, 12:20 Hrs [IST] Granules India, a generic ...

Dehydrolactone (middle panel) in a polypeptide undergoes an intermolecular rearrangement to generate a ketide with a new carbon-carbon bond in the backbone. The researchers installed dehydrolactone in ...